Table of Contents
Chemotherapy Research and Practice
Volume 2015, Article ID 197871, 4 pages
http://dx.doi.org/10.1155/2015/197871
Clinical Study

Postchemotherapy Histopathological Evaluation of Ovarian Carcinoma: A 40-Case Study

1Department of Pathology, GGS Medical College, Faridkot, Punjab 151203, India
2Department of Radiotherapy, GGS Medical College, Faridkot 151203, India

Received 25 September 2014; Revised 11 December 2014; Accepted 5 January 2015

Academic Editor: Paolo Pronzato

Copyright © 2015 Kanwardeep Kaur Tiwana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Agarwal, K. P. Malhotra, S. Sinha, and S. Rajaram, “Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade: comparative evaluation with international data,” Indian Journal of Cancer, vol. 49, no. 3, pp. 298–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Momtahen, M. Kadivar, A. S. Kazzazi, and F. Gholipour, “Assessment of gynecologic malignancies: a multi-center study in Tehran (1995–2005),” Indian Journal of Cancer, vol. 46, no. 3, pp. 226–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. U.S. Cancer Statistics Working Group, Unites States Cancer Stastistics: 1999–2011 Incidence and Mortality Web-Based Report, Department of Health and Human Services, Centers For Disease Control and Prevention and National Cancer Institute, Atlanta, Ga, USA, 2014.
  4. D. Samrao, D. Wang, F. Ough et al., “Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy,” Translational Oncology, vol. 5, no. 6, pp. 469–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. E. Winter III, G. L. Maxwell, C. Tian et al., “Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study,” Journal of Clinical Oncology, vol. 25, no. 24, pp. 3621–3627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Skírnisdóttir and B. Sorbe, “Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma,” International Journal of Oncology, vol. 30, no. 3, pp. 727–734, 2007. View at Google Scholar · View at Scopus
  7. R. Langer, K. Ott, M. Feith, F. Lordick, J.-R. Siewert, and K. Becker, “Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas,” Modern Pathology, vol. 22, no. 12, pp. 1555–1563, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-T. Wu, L. R. Chirieac, S. C. Abraham et al., “Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome,” The American Journal of Surgical Pathology, vol. 31, no. 1, pp. 58–64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Wang, Y. Wang, and W. Zheng, “Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapy,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 10, pp. 2121–2128, 2013. View at Google Scholar · View at Scopus
  10. W. G. McCluggage, R. W. Lyness, R. J. Atkinson et al., “Morphological effects of chemotherapy on ovarian carcinoma,” Journal of Clinical Pathology, vol. 55, no. 1, pp. 27–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Miller, J. H. Price, S. P. Dobbs, R. H. McClelland, K. Kennedy, and W. G. McCluggage, “An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma,” Journal of Clinical Pathology, vol. 61, no. 5, pp. 652–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Shimosato, S. Oboshi, and K. Baba, “Histologic evaluation of effects of radiotherapy and chemotherapy for carcinomas,” Japanese Journal of Clinical Oncology, vol. 1, no. 1, pp. 19–35, 1971. View at Google Scholar · View at Scopus
  13. K. Junker, K. Langner, F. Klinke, U. Bosse, and M. Thomas, “Grading of tumor regression in non-small cell lung cancer: morphology and prognosis,” Chest, vol. 120, no. 5, pp. 1584–1591, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Shia, J. G. Guillem, H. G. Moore et al., “Patterns of morphological alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome,” The American Journal of Surgical Pathology, vol. 28, no. 2, pp. 215–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. O. C. Freedman, J. Dodge, P. Shaw et al., “Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy,” Gynecologic Oncology, vol. 119, no. 1, pp. 22–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Jass, J. O'Brien, R. H. Riddell, and D. C. Snover, “Recommendations for the reporting of surgically resected specimens of colorectal carcinoma,” American Journal of Clinical Pathology, vol. 129, no. 1, pp. 13–23, 2008. View at Publisher · View at Google Scholar · View at Scopus